Creating a paradigm shift in renal care
October 2018: Quanta Wins Industrial Product Design of the Year at the Plastics Industry Awards 2018
Quanta Dialysis Technologies, today announces that the Company has won the "Industrial Product Design of the Year" award at the Plastics Industry Awards 2018. The design of the SC+ haemodialysis system focuses on providing an intuitive user experience, centring on a large, interactive graphical touchscreen that guides users through a treatment via logical steps. This intuitive, tablet-style approach, combined with ergonomic industrial design, is intended to provide patients with a simple yet powerful platform for managing their treatments around their lives. Furthermore, every detail of the user experience and product design is streamlined to provide maximum safety and ease of use. The small footprint and modern design of the SC+ machine blends unobtrusively into different environments, expanding the range of treatment options available to patients.
Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 11th UK Annual Dialysis Conference, taking place from Thursday 20th to Friday 21st September, at the Lowry Hotel in Manchester, UK. The UK Annual Dialysis Conference theme for 2018 is 'Advancing Dialysis: Now and for the Future' and will focus on clinical challenges, innovative solutions and future advances in dialysis care. Quanta will exhibit the new look of its personal haemodialysis system, SC+, which it plans to launch in 2019. SC+ is designed to give patients flexibility and to empower them to take control of their dialysis, enabling them to fit treatment around everyday life.
Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 55th Annual European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Thursday 24th to Sunday 27th May, at the Bella Center in Copenhagen, Denmark at booth number 4.151. Quanta will be showcasing its new look, state-of-the-art personal haemodialysis system, SC+, designed to offer patients flexibility enabling them to fit treatment around everyday life.
Quanta Dialysis Technologies, today announces that the Company has successfully completed a clinical pilot to treat patients in France. Building off its successful UK pilot, this is the first time Quanta's personal haemodialysis system, SC+ has been used outside the UK. The treatments took place over a two-week period with five patients in Hôpital Necker, Paris. The treatments were led by French nurses who were trained by Quanta. These initial treatments in France were in addition to the ongoing pilot study in the UK, which has so far resulted in more than 1,400 successful patient treatments.
Quanta Dialysis Technologies, today announces that the Company will be presenting at the 38th Annual Dialysis Conference (ADC), which runs from 3 to 6 March 2018 at the Marriott Orlando World Center in Florida, USA. Peter Hoyer, Chief Commercial Officer, will provide an update on Quanta's unique small, simple and powerful haemodialysis system, SC+, in the 'Home HD Machines' session chaired by Robert Lockridge, MD, on Sunday 4 March at 2:15pm. The session will include an update on the results of the SC+ Pilot Study, which includes extensive, successful, patient treatments at four NHS Trusts across the UK.